Coronary Artery Diseases

Cardiovascular
0
Pipeline Programs
2
Companies
5
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Biotronik
BiotronikGermany - Berlin
4 programs
BIOFLOW III Satellite-Italy Orsiro Stent SystemN/A1 trial
BIOFLOW-III VIP Russia Registry Orsiro Stent SystemN/A1 trial
Drug Eluting StentN/A1 trial
OrsiroN/A1 trial
Active Trials
NCT02028728Completed609Est. Jul 2016
NCT02247492Unknown200Est. May 2021
NCT02273648Unknown1,000Est. Sep 2021
+1 more trials
HeartFlow
HeartFlowMOUNTAIN VIEW, CA
1 program
Coronary AngiographyN/A1 trial
Active Trials
NCT02813473CompletedEst. Mar 2018

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
BiotronikBIOFLOW-III VIP Russia Registry Orsiro Stent System
HeartFlowCoronary Angiography
BiotronikOrsiro
BiotronikDrug Eluting Stent
BiotronikBIOFLOW III Satellite-Italy Orsiro Stent System

Clinical Trials (5)

Total enrollment: 2,309 patients across 5 trials

NCT02247492BiotronikBIOFLOW-III VIP Russia Registry Orsiro Stent System

BIOFLOW-III VIP Russia Registry Orsiro Stent System

Start: Apr 2017Est. completion: May 2021200 patients
N/AUnknown
NCT02813473HeartFlowCoronary Angiography

SYNTAX III REVOLUTION Trial: A Randomized Study Investigating the Use of CT Scan and Angiography of the Heart to Help the Doctors Decide Which Method is the Best to Improve Blood Supply to the Heart in Patients With Complex Coronary Artery Disease

Start: Jun 2016Est. completion: Mar 2018
N/ACompleted
NCT02257710BiotronikOrsiro

BIOFLOW-III UK Satellite Registry Orsiro Stent System

Start: Nov 2015Est. completion: Dec 2018500 patients
N/AUnknown
NCT02273648BiotronikDrug Eluting Stent

BIOTRONIK - BIOFLOW-III Registry French Satellite

Start: Nov 2014Est. completion: Sep 20211,000 patients
N/AUnknown
NCT02028728BiotronikBIOFLOW III Satellite-Italy Orsiro Stent System

BIOFLOW III Satellite-Italy Orsiro Stent System

Start: Mar 2014Est. completion: Jul 2016609 patients
N/ACompleted

Related Jobs in Cardiovascular

Embedded Software and System Test Engineer (H/F)

Cardiawave
Levallois-Perret, France (Hybrid)
Just now

Territory Sales Manager - Iowa / Nebraska

HeartFlow
Cedar Rapids, IA; Des Moines, IA; Omaha, NE; Lincoln, NE
Yesterday
From $150K/yr

Associate Regulatory Affairs Specialist

Medtronic
Mounds View, Minnesota, United States of America
Yesterday
$60K - $90K/yr

Business Development Manager, Post Transplant, Cardio Thoracic

Thermo Fisher Scientific
Remote
Yesterday

Director, Medical Affairs

Abbott
Germany - Hesse - Eschborn
Yesterday

Therapy Development Manager

Abbott
Australia > Doncaster : 666 Doncaster Road
Yesterday

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 companies competing in this space

Related Indications

Heart Failure(334)Hypertension(333)Coronary Artery Disease(295)Atrial Fibrillation(288)Pulmonary Arterial Hypertension(103)Acute Coronary Syndrome(62)Pulmonary Hypertension(55)Essential Hypertension(32)Coronary Heart Disease(28)Aortic Valve Stenosis(27)